日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Molecular Testing on Surgical Decision-Making in Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis of Recent Advancements

分子检测对甲状腺结节性质不明患者手术决策的影响:近期进展的系统评价和荟萃分析

Chowdhury, Raisa; Hier, Jessica; Payne, Kayla E; Abdulhaleem, Mawaddah; Dimitstein, Orr; Eisenbach, Netanel; Forest, Véronique-Isabelle; Payne, Richard J

Role of Publicly-Funded Molecular Testing in Surgical Management of Thyroid Nodules within Canadian Medicare: Clinical Assessment of ThyroSeqv3 Molecular Test Pilot Project at McGill University

加拿大医疗保险体系中公共资助的分子检测在甲状腺结节外科治疗中的作用:麦吉尔大学ThyroSeqv3分子检测试点项目的临床评估

Bandargal, Saruchi; Hier, Jessica; Abdulhaleem, Mawaddah; Forest, Véronique-Isabelle; Brassard, Maryse; Rondeau, Geneviève; Dimitstein, Orr; Mascarella, Marco A; Mlynarek, Alex; Hier, Michael P; Richardson, Keith; Sadeghi, Nader; Kost, Karen M; Zeitouni, Anthony; Pusztaszeri, Marc Philippe; Fortier, Pierre; Beaudoin, Danielle; Massicotte, Marie-Helene; Boucher, Andree; Payne, Richard J

Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular Alterations: A Multicenter Retrospective Study

甲状腺癌中TERT启动子分子改变单独存在与合并其他分子改变的临床和组织病理学特征:一项多中心回顾性研究

Steinberg, Emily; Dimitstein, Orr; Morand, Grégoire B; Forest, Véronique-Isabelle; da Silva, Sabrina D; Pusztaszeri, Marc; Alohali, Sama; Payne, Richard J

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

MEK1/2抑制剂可暂时改变肿瘤免疫微环境,从而增强免疫疗法对头颈癌的疗效。

Prasad, Manu; Zorea, Jonathan; Jagadeeshan, Sankar; Shnerb, Avital B; Mathukkada, Sooraj; Bouaoud, Jebrane; Michon, Lucas; Novoplansky, Ofra; Badarni, Mai; Cohen, Limor; Yegodayev, Ksenia M; Tzadok, Sapir; Rotblat, Barak; Brezina, Libor; Mock, Andreas; Karabajakian, Andy; Fayette, Jérôme; Cohen, Idan; Cooks, Tomer; Allon, Irit; Dimitstein, Orr; Joshua, Benzion; Kong, Dexin; Voronov, Elena; Scaltriti, Maurizio; Carmi, Yaron; Conde-Lopez, Cristina; Hess, Jochen; Kurth, Ina; Morris, Luc G T; Saintigny, Pierre; Elkabets, Moshe

IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer

IGF2 介导 HPV 阳性头颈癌对 PI3K 异构体选择性抑制剂的耐药性

Mai Badarni, Manu Prasad, Artemiy Golden, Baisali Bhattacharya, Liron Levin, Ksenia M Yegodayev, Orr Dimitstein, Ben-Zion Joshua, Limor Cohen, Ekaterina Khrameeva, Dexin Kong, Angel Porgador, Alex Braiman, Jennifer R Grandis, Barak Rotblat, Moshe Elkabets

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

TGF-β 激活的癌症相关成纤维细胞限制西妥昔单抗在头颈癌临床前模型中的疗效

Ksenia M Yegodayev, Ofra Novoplansky, Artemiy Golden, Manu Prasad, Liron Levin, Sankar Jagadeeshan, Jonathan Zorea, Orr Dimitstein, Ben-Zion Joshua, Limor Cohen, Ekaterina Khrameeva, Moshe Elkabets

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy

患者来源异种移植的肿瘤组织外植体培养作为靶向治疗的潜在优先排序工具

Susmita Ghosh, Manu Prasad, Kiran Kundu, Limor Cohen, Ksenia M Yegodayev, Jonathan Zorea, Ben-Zion Joshua, Batel Lasry, Orr Dimitstein, Anat Bahat-Dinur, Aviram Mizrachi, Vladimir Lazar, Moshe Elkabets, Angel Porgador